30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD

ABSTRACT IMPACT: We present preliminary data and an outlined approach to assess peripheral immune changes associated with PTSD in a clinical setting and in a pre-clinical rat model of PTSD. OBJECTIVES/GOALS: We report our methodology and findings indicating a relationship between CNS dopamine signal...

Full description

Bibliographic Details
Main Authors: P. M. Mackie, C. Wilkinson, A. Gopinath, L. Knackstedt, H. Khoshbouei
Format: Article
Language:English
Published: Cambridge University Press 2021-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121006282/type/journal_article
_version_ 1811155363002580992
author P. M. Mackie
C. Wilkinson
A. Gopinath
L. Knackstedt
H. Khoshbouei
author_facet P. M. Mackie
C. Wilkinson
A. Gopinath
L. Knackstedt
H. Khoshbouei
author_sort P. M. Mackie
collection DOAJ
description ABSTRACT IMPACT: We present preliminary data and an outlined approach to assess peripheral immune changes associated with PTSD in a clinical setting and in a pre-clinical rat model of PTSD. OBJECTIVES/GOALS: We report our methodology and findings indicating a relationship between CNS dopamine signaling and peripheral immune cell populations and propose to extend this methodology to a PTSD patient population to elucidate immune-brain connections in this disorder. METHODS/STUDY POPULATION: Using an IRB-approved protocol in collaboration with a board-certified psychiatrist, we will recruit PTSD patients undergoing treatment, newly diagnosed drug-naiive PTSD patients, and age-matched healthy controls. Flow cytometry will be used for immunophenotyping on blood samples from each group. To complement this data, we will also measure serum cytokine levels in each group. In order to elucidate the connection between the observed immunophenotypes in the PTSD population and CNS neurotransmitters levels, we will employ a rodent model of PTSD and high-pressure liquid chromatography to measure dopamine levels in tandem with peripheral immune changes. RESULTS/ANTICIPATED RESULTS: In both humans and rodents with low CNS dopamine, an expansion of monocyte-derived suppressor cells was observed via flow cytometry. We anticipate that human PTSD patients will exhibit a similar expansion in suppressive immune cells’‘ in agreement with existing literature suggesting a chronic inflammatory state in PTSD. Moreover, in an animal model of PTSD we anticipate an inverse correlation between the CNS dopamine levels and the size of the immune suppressor cell population. DISCUSSION/SIGNIFICANCE OF FINDINGS: Our findings will indicate whether altered dopamine neurotransmission underlies peripheral immune system changes in the context of PTSD models and human patients. Thus, these findings will provide an alternative avenue for future investigations on the role of the immune system in PTSD.
first_indexed 2024-04-10T04:31:47Z
format Article
id doaj.art-671709ade23648df8e2046f0941235f1
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:31:47Z
publishDate 2021-03-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-671709ade23648df8e2046f0941235f12023-03-10T07:52:03ZengCambridge University PressJournal of Clinical and Translational Science2059-86612021-03-015888810.1017/cts.2021.62830580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSDP. M. MackieC. WilkinsonA. GopinathL. KnackstedtH. KhoshboueiABSTRACT IMPACT: We present preliminary data and an outlined approach to assess peripheral immune changes associated with PTSD in a clinical setting and in a pre-clinical rat model of PTSD. OBJECTIVES/GOALS: We report our methodology and findings indicating a relationship between CNS dopamine signaling and peripheral immune cell populations and propose to extend this methodology to a PTSD patient population to elucidate immune-brain connections in this disorder. METHODS/STUDY POPULATION: Using an IRB-approved protocol in collaboration with a board-certified psychiatrist, we will recruit PTSD patients undergoing treatment, newly diagnosed drug-naiive PTSD patients, and age-matched healthy controls. Flow cytometry will be used for immunophenotyping on blood samples from each group. To complement this data, we will also measure serum cytokine levels in each group. In order to elucidate the connection between the observed immunophenotypes in the PTSD population and CNS neurotransmitters levels, we will employ a rodent model of PTSD and high-pressure liquid chromatography to measure dopamine levels in tandem with peripheral immune changes. RESULTS/ANTICIPATED RESULTS: In both humans and rodents with low CNS dopamine, an expansion of monocyte-derived suppressor cells was observed via flow cytometry. We anticipate that human PTSD patients will exhibit a similar expansion in suppressive immune cells’‘ in agreement with existing literature suggesting a chronic inflammatory state in PTSD. Moreover, in an animal model of PTSD we anticipate an inverse correlation between the CNS dopamine levels and the size of the immune suppressor cell population. DISCUSSION/SIGNIFICANCE OF FINDINGS: Our findings will indicate whether altered dopamine neurotransmission underlies peripheral immune system changes in the context of PTSD models and human patients. Thus, these findings will provide an alternative avenue for future investigations on the role of the immune system in PTSD.https://www.cambridge.org/core/product/identifier/S2059866121006282/type/journal_article
spellingShingle P. M. Mackie
C. Wilkinson
A. Gopinath
L. Knackstedt
H. Khoshbouei
30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
Journal of Clinical and Translational Science
title 30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
title_full 30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
title_fullStr 30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
title_full_unstemmed 30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
title_short 30580 A TL1 Approach to Assessing Peripheral Immune Changes in PTSD
title_sort 30580 a tl1 approach to assessing peripheral immune changes in ptsd
url https://www.cambridge.org/core/product/identifier/S2059866121006282/type/journal_article
work_keys_str_mv AT pmmackie 30580atl1approachtoassessingperipheralimmunechangesinptsd
AT cwilkinson 30580atl1approachtoassessingperipheralimmunechangesinptsd
AT agopinath 30580atl1approachtoassessingperipheralimmunechangesinptsd
AT lknackstedt 30580atl1approachtoassessingperipheralimmunechangesinptsd
AT hkhoshbouei 30580atl1approachtoassessingperipheralimmunechangesinptsd